Related Experiment Video
Updated: Jul 3, 2026
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Time to foster a rational approach to preventing cardiovascular morbid events
1Rasmussen Center for Cardiovascular Disease Prevention, University of Minnesota Medical School, Minneapolis, Minnesota 55455, USA. cohnx001@umn.edu
Insights
This study introduces a novel disease scoring system for preventing atherosclerotic events by detecting arterial and cardiac abnormalities early. Further research is needed to validate its clinical application and effectiveness in guiding therapy.
Area of Science:
- Cardiovascular Medicine
- Diagnostic Imaging
- Preventive Cardiology
Background:
- Traditional atherosclerotic event prevention relies on risk factor management.
- Cardiovascular abnormalities are detectable before symptomatic disease onset.
- Noninvasive techniques enable early disease detection for clinical decision-making.
Discussion:
- A new disease scoring system utilizes 10 tests of vascular and cardiac function and structure.
- This system aims to identify early cardiovascular abnormalities for more precise therapeutic guidance.
- Shifting focus from risk factors to early disease detection offers improved sensitivity and specificity.
Key Insights:
- Early detection of subclinical cardiovascular abnormalities is crucial for preventing major adverse cardiovascular events.
- A comprehensive scoring system integrating multiple noninvasive tests shows promise for personalized risk assessment.
- The developed scoring system represents a potential paradigm shift in managing atherosclerotic disease.
Outlook:
- Further validation studies are required to confirm the scoring system's sensitivity and specificity.
- Demonstrating the system's utility in monitoring therapeutic response is essential for widespread adoption.
- Widespread clinical application hinges on robust evidence supporting its impact on patient outcomes.
Abstract:
Efforts to prevent atherosclerotic morbid events have focused primarily on risk factor prevention and intervention. These approaches, based on the statistical association of risk factors with events, have dominated clinical practice in the last generation. Because the cardiovascular abnormalities eventuating in morbid events are detectable in the arteries and heart before the development of symptomatic disease, recent efforts have focused on identifying the presence of these abnormalities as a more sensitive and specific guide to the need for therapy. Advances in noninvasive techniques for studying the vasculature and the left ventricle now provide the opportunity to use early disease rather than risk factors as the tool for clinical decision making. A disease scoring system has been developed using 10 tests of vascular and cardiac function and structure. More extensive data to confirm the sensitivity and specificity of this scoring system and to demonstrate its utility in tracking the response to therapy are needed to justify widespread application in clinical practice.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
01:26Atherosclerosis III: Management
01:26Coronary Artery Disease II: Pathophysiology
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
01:30Coronary Artery Disease I: Introduction
01:21Rheumatic Heart Disease III: Medical Management